CA4 and neoplasm: Although the human anti-CD19 (Hu1E7) scFv showed relatively lower binding ability compared to that of the murine anti-CD19 (FMC63) scFv, Hu1E7-CAR4 T cells and mFMC63-CAR4 T cells demonstrated similar anti-tumor activities and cell proliferation.